4DMedical Overview
- Year Founded
-
2012
- Status
-
Public
- Employees
-
138
- Stock Symbol
-
4DX
- Investments
-
3
- Share Price
-
$1.57
- (As of Friday Closing)
4DMedical General Information
Description
4DMedical Ltd is a medical technology company developing imaging software for respiratory care. Its product portfolio includes XV Lung Ventilation Analysis Software (XV LVAS), CT LVAS, and CT, which are used to analyze lung ventilation and perfusion from medical imaging. The company delivers its software through a software-as-a-service (SaaS) model for integration with hospital systems and incorporates artificial intelligence capabilities into its imaging solutions. Geographically, the company generates key revenue from United States followed by Australia. The company also expanded its commercial presence across Europe, Canada, New Zealand and Brazil.
Contact Information
Website
www.4dmedical.comCorporate Office
- 700 Swanston Street
- Level 7
- Carlton, Victoria 3053
- Australia
Corporate Office
- 700 Swanston Street
- Level 7
- Carlton, Victoria 3053
- Australia
4DMedical Timeline
4DMedical Stock Performance
As of 13-Nov-2026, 4DMedical’s stock price is $1.57. Its current market cap is $943M with 602M shares.
(As of Friday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $1.57 | $1.58 | $0.90 - $5.23 | $943M | 602M | 4.46M |
4DMedical Financials Summary
As of 30-Sep-2026, 4DMedical has a trailing 12-month revenue of null.
|
In Thousands, USD |
TTM 30-Sep-2026 | FY 2026 30-Jun-2026 | FY 2025 30-Jun-2025 | FY 2024 30-Jun-2024 |
|---|---|---|---|---|
| EV | 1,600,351 | 1,830,874 | 65,710 | 106,538 |
| Revenue | 4,721 | 3,739 | 1,999 | |
| EBITDA | (136,746) | (16,118) | (21,521) | |
| Net Income | (138,491) | (19,456) | (23,578) | |
| Total Assets | 251,422 | 61,930 | 80,218 | |
| Total Debt | 7,684 | 2,814 | 3,423 |
4DMedical Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
4DMedical Comparisons
Industry
Financing
Details
4DMedical Competitors (14)
One of 4DMedical’s 14 competitors is Fluidda, a Private Equity-Backed company based in Belgium.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Fluidda | Private Equity-Backed | Belgium | ||||
| SentiAR | Venture Capital-Backed | Saint Louis, MO | ||||
| Foundation Medicine | Formerly VC-backed | Boston, MA | ||||
| Uptake Medical | Formerly VC-backed | San Jose, CA | ||||
| Genomic Expression | Venture Capital-Backed | Beverly, MA |
4DMedical Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
4DMedical Patents
4DMedical Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| AU-2026904698-A0 | System and method for detecting lung disease | Pending | 15-May-2026 | ||
| AU-2026904701-A0 | System and method for predicting lung disease | Pending | 15-May-2026 | ||
| AU-2025905151-A0 | Method and system for measuing regional perfusion of the lungs | Pending | 29-Oct-2025 | ||
| AU-2024903175-A0 | Method of detecting lung disease based on ventilation of the lung | Pending | 01-Oct-2024 | ||
| AU-2024901471-A0 | Method and system for detecting lung disease | Pending | 19-May-2024 |
4DMedical Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
4DMedical Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
4DMedical Investments & Acquisitions (3)
4DMedical’s most recent deal was a Later Stage VC with RevealDX for . The deal was made on 03-Aug-2026.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| RevealDX | 03-Aug-2026 | Later Stage VC | Decision/Risk Analysis | ||
| Contextflow | 31-Jul-2026 | Merger/Acquisition | Decision/Risk Analysis | ||
| Imbio | 18-Dec-2023 | Merger/Acquisition | Decision/Risk Analysis |
4DMedical ESG
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
Rank
Percentile
Software & Services
Industry
Rank
Percentile
IT Consulting
Subindustry
Rank
Percentile
4DMedical Affiliates
Subsidiaries (1)
| Name | Industry | Location | Year Founded |
|---|---|---|---|
| Imbio | Minneapolis, MN | 2005 |
4DMedical FAQs
-
When was 4DMedical founded?
4DMedical was founded in 2012.
-
Where is 4DMedical headquartered?
4DMedical is headquartered in Carlton, Australia.
-
What is the size of 4DMedical?
4DMedical has 138 total employees.
-
What industry is 4DMedical in?
4DMedical’s primary industry is Diagnostic Equipment.
-
Is 4DMedical a private or public company?
4DMedical is a Public company.
-
What is 4DMedical’s stock symbol?
The ticker symbol for 4DMedical is 4DX.
-
What is the current stock price of 4DMedical?
As of 13-Nov-2026 the stock price of 4DMedical is $1.57.
-
What is the current market cap of 4DMedical?
The current market capitalization of 4DMedical is $943M.
-
Who are 4DMedical’s competitors?
Fluidda, SentiAR, Foundation Medicine, Uptake Medical, and Genomic Expression are some of the 14 competitors of 4DMedical.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
